Regeneron Pharmaceuticals, Inc… (NASDAQ:REGN)

buy sell stocks

Top Analyst Upgrades and Downgrades: ArcelorMittal, Boeing, Intel, Schlumberger, Yahoo, Vivint Solar, Johnson & Johnson and More

Stocks were indicated higher yet again on Wednesday, with the Dow over 18,000 and the S&P 500 back at 2,100. The memories of all the selling pressure during the first ...
Read Full Story »
clinical trials

Regeneron Rises on Positive Top-Line Results

Regeneron Pharmaceuticals Inc. (NASDAQ: REGN), in conjunction with Sanofi, released top-line results for its most recent late-stage study. The companies announced that two placebo-controlled Phase 3 studies evaluating investigational dupilumab ...
Read Full Story »
Pills and tablets

Regeneron and Sanofi Plan to Appeal Amgen Patent Verdict

Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) saw its shares halted on Wednesday afternoon after a jury ruled in favor of Amgen Inc. (NASDAQ: AMGN) on a cholesterol drug patent. However, Regeneron ...
Read Full Story »
clinical trials

Regeneron Scores Win in Late-Stage Rheumatoid Arthritis Trial

Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) scored a win in a late-stage trial for the treatment of rheumatoid arthritis (RA). The company, in conjunction with Sanofi, announced that a Phase 3 ...
Read Full Story »
biotech word cloud

Why Citi Sees Huge Upside in 4 Top Biotechs Now

If there was one sector inside of a broader health care theme that performed well through much of 2015, it was biotech. That was then, and this is now. A ...
Read Full Story »
automatic inspection machine

Regeneron Falls on Missed Earnings

Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) reported its fourth-quarter financial results before the markets opened on Tuesday. The company had $2.83 in earnings per share (EPS) on $1.10 billion in revenue, ...
Read Full Story »
sadness check box

Regeneron Downgrade Highlights at Least Some Risks

Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) seems to have held up rather well against an analyst downgrade on Wednesday. Canaccord Genuity lowered its official rating to Hold from Buy. While the ...
Read Full Story »
ThinkstockPhotos-475472230

Top Analyst Upgrades and Downgrades: Apple, AT&T, DuPont, Fitbit, Huntington Bancshares, McDonald’s, Merck, Newmont, Sprint and More

Stocks were indicated lower after companies like Apple, Boeing and AT&T were taking shareholders down after earnings. The volatility in 2016 remains in place. While investors may have seen every ...
Read Full Story »
Biotechnology word cloud

UBS Loves These 3 Top Biotech Stock Leaders Into Q3 Earnings

If there has been one sector that wishes the 2016 election was already here and gone, it is biotechnology. Shrill political rhetoric over drug pricing and further regulations hammered the ...
Read Full Story »
Monkey evil

Top Analyst Upgrades and Downgrades: AIG, Facebook, Gilead, Google, Regeneron, Twitter, Valeant, Vertex and More

Stocks were indicated higher on Friday going into the unemployment and payrolls report. Investors want to keep buying value and discounted shares on the dips. That trend is now four ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Amgen, Dow, Fitbit, Office Depot, SanDisk, Wells Fargo, Yum and Many More

Stocks were indicated substantially higher on Tuesday morning after the Labor Day weekend. China shares were higher, as was Europe. The trend of buying pullbacks lives on. 24/7 Wall St. ...
Read Full Story »
Sell Button

4 Stocks to Sell Now, Until the Fed Acts

Monday was historic. The Dow Jones had a 7% intraday trading range. The Nasdaq was even more volatile with a 9% intraday trading range. The S&P 500 had gained more ...
Read Full Story »
biotech

3 Large Biotech Stocks to Buy Despite Higher Interest Rates Coming

With many now expecting interest rates to finally start the move higher as early as next month, it is a fascinating study to see how interest rates affect biotech stocks. ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Apple, Cheniere, First Solar, Hilton, NOV, Disney and Many More

Stocks traded higher early Wednesday, a show that yet again investors are buyers after every stock market dip. That trend is now almost four years old, although the reason for buying the ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Baidu, BlackBerry, GM, PayPal, Teva, Yelp and Many More

Stocks were indicated higher on Tuesday morning after 5 days in a row of selling. Yet again we see the trend of investors finding a reason to buy every stock ...
Read Full Story »